This study investigates the detection of circulating and disseminated tumor cells (CTCs/DTCs) and circulating cell-free (cf) DNA in the blood, urine, and bone marrow of patients with solid primary cancers. The purpose is to increase understanding of cancer spread and advance individualized therapies and screening methods.
The study focuses on evaluating the genetic and phenotypic characteristics of CTCs/DTCs and cfDNA. It seeks to understand their role in cancer biology and potential for early detection.
- Who can participate: Adults over 18 years with a diagnosis of solid cancer, including lung, esophageal, stomach, bile duct/pancreas, colorectal, melanoma, and sarcoma, can participate. High-risk individuals aged 55-80 years with a significant smoking history are also eligible.
- Study details: Participants will provide blood, urine, and possibly bone marrow samples for analysis.
How understandable was the trial content above?
Hard to understand
Easy to understand